Drugs for life [electronic resource] : how pharmaceutical companies define our health / Joseph Dumit.
Joseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment.
Saved in:
| Online Access: |
Full Text (via Duke) |
|---|---|
| Main Author: | |
| Other title: | How pharmaceutical companies define our health. |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Durham, N.C. :
Duke University Press,
2012.
|
| Series: | Experimental futures.
|
| Subjects: |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | b9035642 | ||
| 003 | CoU | ||
| 005 | 20221007045111.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 120911s2012 ncua ob 001 0 eng d | ||
| 019 | |a 812251442 |a 880909112 |a 1055240250 |a 1078866762 |a 1086444092 |a 1125495765 |a 1136428743 |a 1141677143 |a 1142793009 |a 1153026816 |a 1154259871 |a 1167395177 |a 1170308114 |a 1170527243 |a 1229663719 |a 1236196440 |a 1245476656 |a 1266909696 | ||
| 020 | |a 9780822393481 |q (electronic bk.) | ||
| 020 | |a 0822393484 |q (electronic bk.) | ||
| 020 | |a 9786613904102 | ||
| 020 | |a 6613904104 | ||
| 020 | |a 1283591650 | ||
| 020 | |a 9781283591652 | ||
| 020 | |z 9780822348603 |q (cloth ; |q alk. paper) | ||
| 020 | |z 0822348608 |q (cloth ; |q alk. paper) | ||
| 020 | |z 9780822348719 |q (pbk. ; |q alk. paper) | ||
| 020 | |z 0822348713 |q (pbk. ; |q alk. paper) | ||
| 024 | 7 | |a 10.1515/9780822393481 | |
| 024 | 8 | |a 9786613904102 | |
| 035 | |a (OCoLC)dup809653753 | ||
| 035 | |a (OCoLC)809653753 |z (OCoLC)812251442 |z (OCoLC)880909112 |z (OCoLC)1055240250 |z (OCoLC)1078866762 |z (OCoLC)1086444092 |z (OCoLC)1125495765 |z (OCoLC)1136428743 |z (OCoLC)1141677143 |z (OCoLC)1142793009 |z (OCoLC)1153026816 |z (OCoLC)1154259871 |z (OCoLC)1167395177 |z (OCoLC)1170308114 |z (OCoLC)1170527243 |z (OCoLC)1229663719 |z (OCoLC)1236196440 |z (OCoLC)1245476656 |z (OCoLC)1266909696 | ||
| 035 | |a (OCoLC)809653753 |z (OCoLC)812251442 |z (OCoLC)880909112 |z (OCoLC)1055240250 |z (OCoLC)1078866762 |z (OCoLC)1086444092 |z (OCoLC)1125495765 |z (OCoLC)1136428743 |z (OCoLC)1141677143 |z (OCoLC)1142793009 |z (OCoLC)1153026816 |z (OCoLC)1154259871 |z (OCoLC)1167395177 |z (OCoLC)1170308114 |z (OCoLC)1170527243 |z (OCoLC)1229663719 | ||
| 035 | |a (OCoLC)809653753 |z (OCoLC)812251442 |z (OCoLC)880909112 | ||
| 040 | |a CUS |b eng |e pn |c CUS |d YDXCP |d NDD |d GPM |d LRU |d E7B |d ZMC |d OCLCQ |d N$T |d CDX |d OCLCO |d MHW |d MEAUC |d OCLCF |d DEBSZ |d NAM |d NHM |d OCLCO |d AU@ |d OCLCQ |d Z5A |d OCLCO |d OCLCA |d MERUC |d OCLCO |d IOG |d GILDS |d OCLCA |d OTZ |d COCUF |d OCLCQ |d TKN |d CANPU |d OCLCO |d OCLCA |d BRX |d VDB |d OCLCO |d OCLCQ |d BWN |d SFB |d OCLCA |d OCLCE |d OCLCA |d VT2 |d OCLCQ |d U9X |d JSTOR |d LUN |d DEGRU |d LVT |d OCLCQ |d OCLCO |d AUD |d QGK |d UKAHL |d DGITA |d OCLCO |d KSU |d OCL |d OCLCQ | ||
| 042 | |a dlr | ||
| 043 | |a n-us--- | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a HD9666.5 |b .D86 2012eb | |
| 100 | 1 | |a Dumit, Joseph. |0 http://id.loc.gov/authorities/names/n97045640 |1 http://isni.org/isni/0000000055128221. | |
| 245 | 1 | 0 | |a Drugs for life |h [electronic resource] : |b how pharmaceutical companies define our health / |c Joseph Dumit. |
| 246 | 3 | 0 | |a How pharmaceutical companies define our health. |
| 260 | |a Durham, N.C. : |b Duke University Press, |c 2012. | ||
| 300 | |a 1 online resource (xii, 262 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 347 | |a text file. | ||
| 347 | |b PDF. | ||
| 490 | 1 | |a Experimental futures. | |
| 504 | |a Includes bibliographical references (pages 239-256) and index. | ||
| 505 | 0 | 0 | |t Responding to facts -- |t Pharmaceutical witnessing and direct-to-consumer advertising -- |t Having to grow medicine -- |t Mass health: illness is a line you cross -- |t Moving the lines: deciding on thresholds -- |t Knowing your numbers: pharmaceutical lifestyles -- |t Living in a world of surplus health: frequently asked questions. |
| 520 | |a Joseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. | ||
| 520 | |a "Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs."--Provided by publisher. | ||
| 546 | |a English. | ||
| 588 | 0 | |a Online resource; title from digital title page (ebrary platform, viewed June 4, 2014) | |
| 650 | 0 | |a Pharmaceutical industry |x Social aspects |z United States. | |
| 650 | 0 | |a Drugs |x Social aspects |z United States. | |
| 650 | 0 | |a Drug utilization |z United States. |0 http://id.loc.gov/authorities/subjects/sh2009123866. | |
| 650 | 0 | |a Social ecology. |0 http://id.loc.gov/authorities/subjects/sh92004049. | |
| 650 | 7 | |a Social ecology. |2 fast |0 (OCoLC)fst01122434. | |
| 650 | 7 | |a Drug utilization. |2 fast |0 (OCoLC)fst00898740. | |
| 650 | 7 | |a Drugs |x Social aspects. |2 fast |0 (OCoLC)fst00898917. | |
| 650 | 7 | |a Pharmaceutical industry |x Social aspects. |2 fast |0 (OCoLC)fst01060175. | |
| 651 | 7 | |a United States. |2 fast |0 (OCoLC)fst01204155. | |
| 776 | 0 | 8 | |i Print version: |a Dumit, Joseph. |t Drugs for life. |d Durham, NC : Duke University Press, 2012 |z 9780822348603 |z 0822348608 |w (DLC) 2012011596 |w (OCoLC)782252371. |
| 830 | 0 | |a Experimental futures. |0 http://id.loc.gov/authorities/names/no2008088664. | |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=http://dx.doi.org/10.1215/9780822393481?locatt=mode:legacy |z Full Text (via Duke) |
| 907 | |a .b90356421 |b 11-01-22 |c 02-14-17 | ||
| 998 | |a web |b 10-11-22 |c b |d b |e - |f eng |g ncu |h 0 |i 1 | ||
| 907 | |a .b90356421 |b 10-11-22 |c 02-14-17 | ||
| 944 | |a MARS - RDA ENRICHED | ||
| 915 | |a - | ||
| 956 | |a e-Duke books scholarly collection | ||
| 956 | |b 2012 e-Duke Books Scholarly Collection | ||
| 999 | f | f | |i 55d04906-14ae-5666-8402-8b7dad49269f |s 534d8bb5-7d82-5bf4-a3f4-347b79c6faf6 |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e HD9666.5 .D86 2012eb |h Library of Congress classification |i web |n 1 |